NCT06189820View on ClinicalTrials.gov

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

March 9, 2027

Study Completion Date

March 9, 2027

Conditions
Pulmonary FibrosisLung FibrosisIdiopathic Pulmonary FibrosisFAP
Interventions
DIAGNOSTIC_TEST

FAPI PET/CT

"In the department of Nuclear Medicine:~* Installation in a relax chair after weight and height control~* Placement of a venous line in the upper limb after which an infusion of 500ml of 0.9% NaCl is started.~* Intravenous injection of 3 MBq/kg (max 300 MBq) of 18F- FAPI 74 or of 2 MBq/kg 68Ga-FAPI46"

Trial Locations (1)

1070

RECRUITING

Medecine, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER